Taurine and glucose metabolism: A review

Nutricion Hospitalaria

Volumn 25, Issue 6, 2010, Pages 910-919

  De La Puerta, C ^a   Arrieta, F J ^a   Balsa, J A ^a   Botella Carretero, J I ^a   Zamarron I ^a   Vazquez C ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Jefe de Servicio   (Spain)

Author keywords

Anti inflammation; Cardiovascular health; Diabetes; Diabetes complications; Oxidative damage; Taurine

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GLUCOSE; INSULIN; TAURINE;

ANIMAL; DIABETES MELLITUS; HOMEOSTASIS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; TAURINE;

EID: 78649535192     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.6.4815     Document Type: Review

References (57)

1. Kim SJ, Gupta RC, Lee HW. Taurine-diabetes interaction: from involvement to Protection. Curr Diabetes Rev 2007; 3 (3): 165-175.
2. Lourenço R, Camilo ME. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 2002; 17 (6): 262-270.
3. Bouceknooghe T, Remacle C, Reusens B. Is taurine a functional nutrientín Current Opinion in Clinical Nutrition and Metabolic Care 2006; 9: 728-733.
4. Szymanski K, Winiarska K. Taurine and its potential therapeutic application. Postepy Hig Med Dosw (Online) 2008; 62: 75-86.
5. Schaffer SW, Azuma J, Mozaffari M. Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 2009; 87: 91-99.
6. Suzuki T, Suzuki T, Wada T, Saigo K,Watanabe K. Novel taurine- containing uridine derivatives and mitochondrial human diseases. Nucleic Acids Res Suppl 2001; (1): 257-258.
7. Franconi F, Di Leo MA, Bennardini F, Ghirlanda G. Is Taurine Beneficial in Reducing Risk Factors for Diabetes Mellitus? Neurochemical Research 2004; 29 (1): 143-150.
8. Takeo Suzuki, Tsutomu Suzuki, Takeshi Wada, Kazuhiko Saigo, Kimitsuna Watanabe. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrialdiseases. EMBO J 2002; 21 (23): 6581-6589.
9. Gurujeyalakshmi G, Wang Y, and Giri S.N. Suppression of bleomycin-induced nitric-oxide production in mice by taurine and niacin. Adv Exp Med Biol 2000; 483: 545-61.
10. Wu H, JIN Y, Wei J, Jin H, Sha D, Wu JY. Mode of action of taurine as a neuroprotector. Brain Res 2005; 1038: 123-131.
11. Merezak S, Hardikar AA, Yajnik CS, Remacle C, Reusens B. Intrauterine low protein diet increases fetal -cell sensitivity to NO and Il-1â. the protective role of taurine. J Endocrinol 2001; 171: 299-308.
12. Hamaguchi T, Azuma J, Schaffer S. Interaction of taurine with methionine: inhibition of myocardial phospholipids mehtyltranferase. J Cardiovasc Pharmacol 2001; 18: 224-230.
13. Yildirim Z, Kilic N, Ozer C, Babul A, Take G. Erdogan D. Aging interventions:effects of taurine in cellular responses to oxidative stress in young and middle-aged rat liver. Ann NY Acad Sci 1995; 1100: 553-561.
14. Nonaka H, Tsujino T, Watari y, Enoto N, Yokoyama M. Taurine prevents the the decrease in expression and secretion of extracellular superoxide dismutase induced by homocystein amelioration of homocystein-induced endoplasmic reticulum stress by taurine. Circulation 2001; 104: 1165-1170.
15. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation. J Clin Inves 1982; 70 (3): 598-607.
16. Park, E, Alberti J, Quinn M.R., Schuller-Levis G. Taurine chloramines inhibits production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. Adv Exp Med Biol 442: 177-182.
17. Kontny AK, Scczepanska K, Kowalczewski J, Kurowska M, Janicha I, Marcinkiewicz J, Maslinski W. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis. Arthritis Rheum 2000; 43: 2169-2177.
18. Hansen SH. The role of taurine in diabetes and the development of diabetic Complications. Diabetes Metab Res Rev 2001; 17: 330-346.
19. Pasentes-morales H, Schousboe A. Role of taurine in osmoregulation in brain cells: mechanisms and functional implications. Amino Acids 1997; 12: 281-292.
20. Stevens MJ, Hosaka Y, Masterson JA, Jones SM, Thomas TP, Larkin DD. Downregulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells. Am J Physiol 1999; 277: E760-E771.
21. Amira El-Sherbeny, Hany Naggar, Seiji Miyauchi, M. Shamsul Ola, Dennis M Maddox, Pamela Moore Martin, Vadiviel Ganapathy, Sylvia B. Smith. Osmoregulation of Taurine transporter Function and Expression in Retinal Pigment Epithelial, Ganglion and másler Cells. Investigative Ophthalmology & Visual Science. 2004. Vol 45, No 2.
22. Kulakowski EC, Maturo J. Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 1984; 33: 2835-2838.
23. Carneiro EM, Latorraca MQ, Araujo E, Beltrárm, Oliveras MJ, Navarro M, Bern?G, Bedoya FJ, Velloso LA, Soria B, Martin F. Taurine supplementation modulates glucose homeostasis and islet function. Journal of Nutritional Biochemistry 2009; 20: 503-511.
24. Lapson WG, Kramer JH, Schaffer SW. Potentiation of the actions of insulin by taurine. Can J Physiol Pharmacol 1983; 61: 457-463.
25. Maturo J, Kulakowski EC. Taurine binding to the purified insulin receptor. Biochem Pharmacol 1988; 37: 3755-3760.
26. Higo S, Miyata S, Jiang QY, Kitazawa R, Kitazawa S, Kasuga M. Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats. Kobe J Med Sci 2008; 54 (1): E35-45.
27. Xiao C, Giacca A, Lewis GF. Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell-function in obese and overweight, non-diabetic men. Diabetología 2008; 51: 139-146.
28. Ribeiro RA, Bonfleur ML, Amaral AG, Vanzela EC, Rocco SA, Boschero AC, CarneiroEM.Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets. Diabetes Metab Res Rev 2009; 25 (4): 370-379.
29. Nandhini AT, Thirunavukkarasu V, Anuradha CV. Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 2005; 31 (4 Pt 1): 337-344.
30. Gavrovskaya LK, Ryzhova OV, Safonova AF, Matveev AK, Sapronov NS. Protective effect of taurine on rats with experimental insulin-dependent diabetes mellitus. Bull Exp Biol Med 2008; 146 (2): 226-228.
31. Lee SH, Lee HY, Kim SY, Lee IK, Song DK. Enhancing effect of taurine on glucose response in UCP-overexpressing beta cells. Diabetes Res Clin Pract 2004; 66: S69-74.
32. C Brons, C Spohr, H Storgaard, J Dyerberg, A. Vaag. Effect of taurine treatment on insulin secretion and action on serum lipid levels in overweighted men with genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 2004; 58(9): 1239-1247.
33. Giusseppe Seghieri, Federica Tesi, Loria Bianchi, Alberto Loizzo, Giuseppe Sacommanni, Giovanni Ghirlanda, Roberto Anichini, Flavia Franconi. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007; 76: 187-192.
34. Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie 2009; 91 (2): 261-270.
35. Yu X, Xu Z, Mi M, Xu H, Zhu J, Wei N, Chen K, Zhang Q, Wang J, Chen F; Tang Y. Dietary taurine supplementation ameliorates diabetic retionpathy via-anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res 2008; 33 (3): 500-507.
36. Pop-Busui, R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular and functional deficits. Exp Neurol 2001; 168: 259-272.
37. Xu Xj, Arneja AS, Tappia PS, Dhalla NS. The potential health benefits of taurine in cardiovascular disease. Exp Clin Cardiol 2008; 13 (2): 57-65.
38. Hadi AR Hadi, Jassim Al Suwaidi. Endothelial dysfunction in diabetes mellitus.Vascular Health and Risk Management 2007; 3 (6): 853-876.
39. Murakami S, Kondo Y, Nagate T. Effects of long-term treatment with taurine in mice fed a high-fat diet: improvement of cholesterol metabolism and vascular lipid accumulation by taurine. Adv Exp med Biol 2000; 483: 177-186.
40. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
41. Zhang M, Bi LF, Su XL, Da GL, Kuwamori T, Kagamori S. Beneficial effects of taurine on serum lipids in overweightedor obese non-diabetic subjects. Amino Acids 2004; 26: 267-271.
42. Mizushima S, Nara Y, Sawamura M, Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 1996; 403: 615-622.
43. Ulrich-Merzenich G, Zeitler H, Vetter H, Bhonde RR. Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins. Eur J Nutr 2007; 46: 431-438.
44. Casey RG, Gang C, Joyce M, Bouchier-Hayes DJ. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J Vasc Res 2007; 44 (1): 31-39.
45. Liu Y, Tonna-DeMasi M, Park E, Schuller-Levis, Quinn MR. Taurine chloramine inhibits production of nitric oxide and prostaglandin E2 in activated C6 glioma cells by suppressing inducible nitric oxide synthase and cyclooxygenase- 2 expression. Brain Res Mol Brain Res 1998; 59 (2): 189-195.
46. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomiopathy: Mechanisms, diagnosis and treatment. Clin Sci (Lond) 2004; 107; 539-557.
47. Wang LJ, Yu YH, Wang Y, Niu N, Li Q, Guo LM. Effects of early intervention with taurine on oxLDL/LOX-1 system and vascular endothelial dysfunction in young streptozotocininduced diabetic rats. Zhonghua Er Ke Za Zhi 2009; 47 (3): 194-199.
48. Ulrich-Merzenich G, Zeitler H,Vetter H, Bhonde RR: Protective effects of taurine on endotelial cells impaired by high glucose and oxidized low density lipoproteins. Eur J Nutr 2007; 46: 431-438.
49. Rasouli ML, Nasir K, Blumenthal RS, Park R, Aziz DC, Budoff MJ. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 2005; 181 (1): 159-165.
50. Ahn CS. Effect of Taurine Supplementation on Plasma Homocysteine Levels of the Middle-Aged Korean Women. Adv Exp Med Biol 2009; 643: 415-422.
51. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Bartolomei G, Anichini R and Seghieri G. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: Effects of taurine supplemmentation. Am J Clin Nutr 1995; 61 (5): 1115-1119.
52. Spohr C, Brós C, Winther K, Dyerberg J, Vaag A. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus. Platelets 2005; 16 (5): 301-305.
53. Wáncik OP et al. The potential protective effects of taurine on coronary heart disease. Atherosclerosis 2010; 208 (1): 19-25.
54. Liu L, Liu I, Ding J et al. Ethnic and environmental differences in various markers of dietary intake and blood pressure among Chinese Han and three other minority peoples of China: results from the WHO cardiovascular disease and alimentary comparison (CARDIAC) study. Hypertens Res 2001; 24 (3): 315-322.
55. Fujita T, Ando K, Noda H, Ito Y, Sato Y. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 1987; 75 (3): 525-532.
56. Hayes KC, Pronczuck A, Addesa AE, Stephan ZF. Taurine modulates platelet aggregation in cats and humans. Am J Clin Nutr 1989; 49: 1211-1216.
57. Ricci C, Pastukh V, Leonard J, Turrens J, Wilson G, Schaffer G, and Shaffer SW. Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol Cell Physiol 2008; 29 (2): 413-422.